1
Rokx, C, Gras, L, van de Vijver, DAMC, Verbon, A, Rijnders, BJA
Veröffentlicht in: HIV Medicine ; volume 17, issue 8, page 571-580 ; ISSN 1464-2662 1468-1293;
2016
Veröffentlicht in: HIV Medicine ; volume 17, issue 8, page 571-580 ; ISSN 1464-2662 1468-1293;
2016
2
3
4
5
6
Akhloufi, H., Streefkerk, R. H., Melles, D. C., de Steenwinkel, J. E. M., Schurink, C. A. M., Verkooijen, R. P., van der Hoeven, C. P., Verbon, A.
Veröffentlicht in: European Journal of Clinical Microbiology & Infectious Diseases ; volume 34, issue 8, page 1631-1637 ; ISSN 0934-9723 1435-4373;
2015
Veröffentlicht in: European Journal of Clinical Microbiology & Infectious Diseases ; volume 34, issue 8, page 1631-1637 ; ISSN 0934-9723 1435-4373;
2015
7
Prins, H. A.B., Zino, L., Svensson, E. M., Verbon, A., de Bree, G. J., Prins, J. M., Reiss, P., Burger, D. M., Rokx, C., Colbers, A.
Veröffentlicht in: Prins , H A B , Zino , L , NOVA Study Team , Svensson , E M , Verbon , A , de Bree , G J , Prins , J M , Reiss , P , Burger , D M , Rokx , C & Colbers , A 2023 , ' Exposure and virologic outcomes of dolutegravir combined with ritonavir boosted darunavir in treatment-naïve individuals enrolled in the Netherlands Cohort Study on Acute HIV infection (NOVA) ' , International Journal of Antimicrobial Agents , vol. 61 , no. 1 , 106697 . https://doi.org/10.1016/j.ijantimicag.2022.106697;
2023
Veröffentlicht in: Prins , H A B , Zino , L , NOVA Study Team , Svensson , E M , Verbon , A , de Bree , G J , Prins , J M , Reiss , P , Burger , D M , Rokx , C & Colbers , A 2023 , ' Exposure and virologic outcomes of dolutegravir combined with ritonavir boosted darunavir in treatment-naïve individuals enrolled in the Netherlands Cohort Study on Acute HIV infection (NOVA) ' , International Journal of Antimicrobial Agents , vol. 61 , no. 1 , 106697 . https://doi.org/10.1016/j.ijantimicag.2022.106697;
2023
8
9
10